Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masahiko Mori is active.

Publication


Featured researches published by Masahiko Mori.


European Journal of Cancer. Part B: Oral Oncology | 1996

Tenascin: Growth and adhesion modulation—Extracellular matrix degrading function: an in Vitro study

Prashanta Shrestha; S. Sumitomo; C.H. Lee; Kuniteru Nagahara; Akihide Kamegai; T. Yamanaka; Hiroshi Takeuchi; M. Kusakabe; Masahiko Mori

Tenascin (TN), a recently characterised extracellular matrix protein, largely confined to the process with the development of embryo in areas of epithelial-mesenchymal interactions and in areas where there are morphogenetic movements and tissue patterning, has a highly restricted expression in adult tissues. The expression of TN is enhanced in a variety of human neoplastic lesions. However, function(s) and molecular mechanisms of enhanced expression in neoplastic lesions remain unclear. We employed human tongue carcinoma cells (SCCKN), human salivary gland adenocarcinoma cells (SGT-1), normal mouse embryonic fibroblasts (NIH3T3-3) and K-ras-2 transformed fibroblasts (Cle-H3) in an in vitro study to elucidate the biological roles of TN. In in vitro studies, all the cell lines examined had enhanced secretion of TN in the presence of transforming growth factor-beta in a dose-dependent manner and TN itself was found to possess a growth-enhancing activity. Moreover, studies on adhesion of the cell lines on coated substrates of fibronectin (FN), laminin (LN), tenascin (TN), TN/FN and TN/LN showed that all the cells adhere and spread well on FN and LN. However, on TN they attach poorly and remain rounded. The relative concentrations of TN and FN affected the cellular adhesion and morphology. In SCCKN and SGT-1, but not in NIH3T3 and Cle-He3 fibroblasts, a higher concentration of TN inhibited cellular adhesion on fibronectin, suggesting that cells attach poorly on TN, it may interfere with the action of fibronectin, and the relative concentrations of TN, FN or LN may affect cellular adhesion and morphology which may differ in different cell types. When TN was added in the growth medium of exponentially growing cells, the cells lost their cell to cell contact and were seen to be separating. The presence of these extracellular matrix proteins were further tested to determine whether they could modulate the secretion of proteolytic enzymes responsible for extracellular matrix degradation by tumour cells, when the neoplastic cells but not the non-neoplastic cells grown on FN/TN substrate showed positive immunofluorescence for collagenase. FN, LN or TN alone did not induce collagenase in the tumour cells. If the same is true in vivo, although a number of factors and interactions may implicate the ultimate outcome, the enhanced expression of TN in neoplastic lesions may have potential implications for tumour growth, differentiation, cellular adhesion, invasion and metastasis.


Journal of Oral Pathology & Medicine | 1996

Immunohistochemical evaluation of the Ca2+‐binding S‐100 proteins S‐100A1, S‐100A2, S‐100A4, S‐100A6 and S‐100B in salivary gland tumors

Jian Wen Huang; Zhao Ming; Prashanta Shrestha; Masahiko Mori; Evelyn C. Ilg; Beat W. Schäfer; Claus W. Heizmann


Anticancer Research | 1996

Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa - a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness

Huynh Anh Lan; Rosnah Binti Zain; M. Saitoh; Y. Muramatsu; P. Shrestha; Masahiko Mori


Anticancer Research | 1996

Tenascin expression in adenoid basal cell carcinoma of the skin

M. Saitoh; Yamada T; P. Shrestha; Yamada K; Tsujimura T; Masahiko Mori


Anticancer Research | 1996

Proliferating patterns of salivary gland adenocarcinomas with the use of PCNA labeling

M Zhao; Qing Xia Zhao; M. Saitoh; H. Ohmura; Y. Okamoto; P. Shrestha; Masahiko Mori


Acta Histochemica Et Cytochemica | 1996

Immunoreactive Metallothionein in Salivary Gland Neoplasms

Prashanta Shrestha; Hisashi Takagi; Yoshiaki Takai; Keiji Suzuki; Masahiko Mori


International Journal of Oncology | 1996

Tenascin in human neoplasia.

Prashanta Shrestha; M. Kusakabe; Masahiko Mori


Acta Histochemica Et Cytochemica | 1996

Immunohistochemical Evaluation of GFAP in Salivary Gland Tumors

Jianwen Huang; Prashanta Shrestha; Yoshiaki Takai; Masahiko Mori


Oncology Reports | 1996

Immunohistochemical study on sebaceous adenoma and sebaceous carcinoma arising in parotid gland

M Zhao; Q Zhao; M. Saitoh; Prashanta Shrestha; Masahiko Mori


International Journal of Oncology | 1996

Heterogeneity of cytokeratin expression as revealed using monoclonal antibodies in salivary adenocarcinomas

M Zhao; Q Zhao; M Saitoh; H. Ohmura; Y. Okamoto; Prashanta Shrestha; Masahiko Mori

Collaboration


Dive into the Masahiko Mori's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge